Carboxylesterase-dependent cytotoxicity of dibasic esters (DBE) in rat nasal explants.
Dibasic esters (DBE) are a solvent mixture of dimethyl adipate (DMA), dimethyl glutarate (DMG), and dimethyl succinate (DMS) used in the paint and coating industry. Subchronic inhalation toxicity studies have demonstrated that DBE induce a mild degeneration of the olfactory, but not the respiratory, epithelium of the rat nasal cavity. Carboxylesterase-mediated hydrolysis of the individual dibasic esters is more efficient in olfactory than in respiratory mucosal homogenates. In the present study, an in vitro system of cultured rat nasal explants was utilized to determine if DBE toxicity is dependent on a metabolic activation by nonspecific carboxylesterase. Explants from both the olfactory and the respiratory regions of the female rat nasal cavity were incubated for 2 hr in Williams' medium E containing 10-100 mM DMA, DMG, or DMS. DBE caused a dose-related increase in nasal explant acid phosphatase release, a biochemical index of cytotoxicity. HPLC analysis demonstrated parallel increases in the carboxylesterase-mediated formation of monomethyl ester metabolites. Diacid metabolite production in the nasal explant system was not entirely concentration-dependent. Metabolite concentrations and acid phosphatase release were generally greater in olfactory than respiratory tissues. DBE-induced cytotoxicity and acid metabolite production were markedly attenuated in nasal tissue excised from rats which were pretreated with bis(p-nitrophenyl)phosphate, a carboxylesterase inhibitor. This study presents a viable in vitro method for assessing organic ester cytotoxicity in the rat nasal cavity. It was shown that DBE are weak nasal toxicants under the conditions of this system. It was further demonstrated that DBE toxicity is dependent on a carboxylesterase-mediated activation. A similar mechanism was proposed for the nasal toxicity induced by other organic esters following inhalation exposure.
Trela
B A
BA
Haskell Laboratory for Toxicology and Industrial Medicine, E. I. du Pont de Nemours & Company, Inc., Newark, Delaware 19714.
Bogdanffy
M S
MS
D000135:Acid Phosphatase / Q000378:metabolism; D000272:Adipates / Q000633:toxicity*; D000280:Administration, Inhalation; D000818:Animals; D002265:Carboxylic Ester Hydrolases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D004305:Dose-Response Relationship, Drug; D005260:Female; D005977:Glutarates / Q000633:toxicity*; D006868:Hydrolysis; D009296:Nasal Cavity / Q000033:anatomy & histology / Q000187:drug effects*; D009297:Nasal Mucosa / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D009596:Nitrophenols / Q000494:pharmacology; D009831:Olfactory Mucosa / Q000187:drug effects; D051381:Rats; D013386:Succinates / Q000633:toxicity*; D013997:Time Factors
D000272:Adipates; D005977:Glutarates; D009596:Nitrophenols; D013386:Succinates; C067353:dimethyl glutarate; C067354:dimethyladipate; C002887:bis(4-nitrophenyl)phosphate; C056451:dimethyl succinate; C067355:estasol; D002265:Carboxylic Ester Hydrolases; D000135:Acid Phosphatase